EASCRA THERAPEUTICS

Serial Number 97074117
602

Registration Progress

Application Filed
Oct 14, 2021
Under Examination
Apr 4, 2023
Approved for Publication
Feb 7, 2023
Published for Opposition
Feb 7, 2023
Registered

Trademark Image

EASCRA THERAPEUTICS

Basic Information

Serial Number
97074117
Filing Date
October 14, 2021
Published for Opposition
February 7, 2023
Abandonment Date
April 25, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
May 9, 2024
Classes
010

Rights Holder

EASCRA BIOTECH INC

03
Address
139A CHARLES ST. #315
BOSTON, MA 02114

Ownership History

Mari Anne Snow

Original Applicant
01
Providence, RI

EASCRA BIOTECH INC

New Owner Before Publication #1
03
BOSTON, MA

EASCRA BIOTECH INC

Owner at Publication
03
BOSTON, MA

Legal Representation

Attorney
Alan Feeney

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
May 9, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
May 9, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jan 24, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jan 24, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 24, 2024 CNFR W SU - FINAL REFUSAL - WRITTEN Loading...
Jan 19, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 19, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 19, 2024 ALIE A ASSIGNED TO LIE Loading...
Aug 29, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 31, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 31, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 31, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
May 16, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 1, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 12, 2023 IUAF S USE AMENDMENT FILED Loading...
Apr 12, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 4, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 3, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 15, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 14, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 14, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 20, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 20, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 20, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 20, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 9, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 3, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 18, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Delivery systems for medicinal therapeutics, namely, Janus Base nanotubes; delivery systems for medicinal therapeutics, namely, mRNA nanotubes; medicinal therapeutics delivery systems for the treatment of diseases, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of cancers and neurological conditions, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of neurological conditions, namely, neurodegenerative diseases, namely, Janus Base nanotubes
First Use Anywhere: Nov 5, 2021
First Use in Commerce: Nov 5, 2021

Additional Information

Translation
The English translation of "EASCRA" in the mark is "BEAKER".

Classification

International Classes
010

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"